Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
258 JPY
1.38 B JPY
55.41 B JPY
5.24 M
About FUSO PHARMACEUTICAL INDUSTRIES
Sector
Headquarters
Osaka
Founded
1937
Website
ISIN
JP3823600006
FIGI
BBG000BG6VY9
Fuso Pharmaceutical Industries, Ltd. engages in the manufacture and sale of ethical pharmaceutical and medical equipment. It operates through the Pharmaceuticals and Real Estate divisions. The Pharmaceuticals division deals with the manufacture and sale of pharmaceutical products which mainly focus on prescription drugs, infusions, and artificial kidney dialysis solutions. The Real Estate division handles leasing of real estate properties. The company was founded on March 25, 1937 and is headquartered in Osaka, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4538 is 2,535 JPY — it has decreased by −0.99% in the past 24 hours. Watch FUSO PHARMACEUTICAL INDUSTRIES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange FUSO PHARMACEUTICAL INDUSTRIES stocks are traded under the ticker 4538.
4538 stock has fallen by −2.07% compared to the previous week, the month change is a −5.11% fall, over the last year FUSO PHARMACEUTICAL INDUSTRIES has showed a 36.66% increase.
4538 reached its all-time high on Apr 14, 2006 with the price of 5,280 JPY, and its all-time low was 1,320 JPY and was reached on Mar 13, 2020. View more price dynamics on 4538 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4538 stock is 1.36% volatile and has beta coefficient of 0.64. Track FUSO PHARMACEUTICAL INDUSTRIES stock price on the chart and check out the list of the most volatile stocks — is FUSO PHARMACEUTICAL INDUSTRIES there?
Today FUSO PHARMACEUTICAL INDUSTRIES has the market capitalization of 21.43 B, it has decreased by −3.13% over the last week.
Yes, you can track FUSO PHARMACEUTICAL INDUSTRIES financials in yearly and quarterly reports right on TradingView.
FUSO PHARMACEUTICAL INDUSTRIES is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
4538 net income for the last quarter is 903.00 M JPY, while the quarter before that showed 632.00 M JPY of net income which accounts for 42.88% change. Track more FUSO PHARMACEUTICAL INDUSTRIES financial stats to get the full picture.
FUSO PHARMACEUTICAL INDUSTRIES dividend yield was 3.18% in 2023, and payout ratio reached 43.77%. The year before the numbers were 3.51% and 38.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 1.84 K employees. See our rating of the largest employees — is FUSO PHARMACEUTICAL INDUSTRIES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FUSO PHARMACEUTICAL INDUSTRIES EBITDA is 5.11 B JPY, and current EBITDA margin is 6.67%. See more stats in FUSO PHARMACEUTICAL INDUSTRIES financial statements.
Like other stocks, 4538 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FUSO PHARMACEUTICAL INDUSTRIES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FUSO PHARMACEUTICAL INDUSTRIES technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FUSO PHARMACEUTICAL INDUSTRIES stock shows the buy signal. See more of FUSO PHARMACEUTICAL INDUSTRIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.